- Corporate Governance
- Information to the Swedish Markets
- Annual Reports
- Management Bios
- News Releases
- Stock Information
- SEC Filings
- Events & Presentations
- Request Information
- Contact Us
Investor Relations
The investor pages that follow are your resource for financial information about Epicept Corporation. In this section you will find information about our current and historical share price, analyst coverage, SEC filings, an electronic version of our annual report and frequently asked questions as well as forms to request additional information.
Immune/EpiCept Corporate Presentation May 2013
[ 1.7 MB ]
View all »
Recent Releases
Feb 12, 2013
EpiCept Corporation and Immune Pharmaceuticals Amend Merger Agreement
Jan 9, 2013
Daniel Teper of Immune Pharmaceuticals to Present at the 6th Annual OneMedForum
View all »Events & Presentations
Nov 14, 2012 at 9:00 AM ET
EpiCept Corporation Third Quarter-2012 Earnings Call
Aug 8, 2012 at 9:00 AM ET
EpiCept Corporation Second Quarter-2012 Earnings Call






